Breast cancer study halted

Jun 20, 2007

The U.S. National Cancer Institute halted a $100 million study of drugs designed to prevent breast cancer in women at risk for the disease.

The study couldn't be justified amid questions of cost, safety and overall benefit, the institute announced Tuesday.

The dangers of introducing these drugs, with their many known side effects, outweighs their potential," the institute said.

While proponents argued the study was crucial to determining the best drugs to prevent breast cancer, other advocacy groups called for more research to better identify women who would benefit most.

The study would have tested a new generation of drugs known as aromatase inhibitors, The Washington Post reported Wednesday. Under the study, about 12,800 women in the United States and Canada would have received raloxifene or the aromatase inhibitor letrozole.

About 180,000 American women are diagnosed with breast cancer each year and about 40,000 die from the disease, making breast cancer the second most common cancer in women.

Copyright 2007 by United Press International

Explore further: Results of new drug, ASP8273, show response in patients with treatment-resistant NSCLC

add to favorites email to friend print save as pdf

Related Stories

Senators get no clear answers on air bag safety

4 hours ago

There were apologies and long-winded explanations, but after nearly four hours of testimony about exploding Takata air bags, senators never got a clear answer to the question most people have: whether or ...

Nicaragua: Studies say canal impact to be minimal

5 hours ago

Officials said Thursday that studies have determined a $40 billion inter-oceanic canal across Nicaragua will have minimal impact on the environment and society, and construction is to begin next month.

Former Brown dean whose group won Nobel Prize dies

5 hours ago

David Greer, a doctor who co-founded a group that won the 1985 Nobel Peace Prize for working to prevent nuclear war and who helped transform the medical school at Brown University, has died. He was 89.

Recommended for you

The STING of radiation

10 hours ago

A team of researchers led by Ludwig Chicago's Yang-Xin Fu and Ralph Weichselbaum has uncovered the primary signaling mechanisms and cellular interactions that drive immune responses against tumors treated with radiotherapy. ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.